Does Preoperative Bisphosphonate Use Impact the Risk of Periprosthetic Fracture Following Total Hip Arthroplasty?
The Journal of Arthroplasty · 2025
DOI: 10.1016/j.arth.2024.08.043 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Rodnell Busigó Torres und 7 weiteren Autor:innen. Beteiligte Einrichtung: Leni and Peter W. May Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Periprosthetic Fractures, Diphosphonates, Bone Density Conservation Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences, Icahn School of Medicine at Mount Sinai.
Abstract (Originalsprache)
BACKGROUND: Bisphosphonate (BP) use is not uncommon among total hip arthroplasty (THA) candidates. While the impact of BP therapy post-THA has been investigated, there is a paucity of literature discussing the impact of BP therapy pre-THA. Using a national dataset, we aimed to study the association between preoperative BP use and surgical outcomes in primary THA recipients. METHODS: This retrospective cohort study used a commercial claims and Medicare Supplemental database to identify adults aged ≥ 18 years who had an index nonfracture-related primary THA from 2016 to 2020. The use of BP was defined as ≥ 6 months of BP therapy in the year prior to THA. Outcomes were 90-day all-cause readmission, 90-day readmission related to periprosthetic fracture (PPF), 90-day and 1-year all-cause revision, 1-year PPF-related revision, and 1-year diagnosis of PPF. In a 1:5 propensity score-matched analysis, each THA patient who had preoperative BP use was matched to five THA patients who did not have preoperative BP use. Logistic regression models were fitted; we report odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Of 91,907 THA patients, 1,018 (1.1%) used BP preoperatively. In the propensity score-matched cohort (1,018 preoperative BP users and 5,090 controls), preoperative BP use was significantly associated with increased odds of 90-day all-cause revision surgery (OR 1.67; 95% CI 1.10 to 2.53; P = 0.02), 1-year PPF-related revision (OR 2.23; 95% CI 1.21 to 4.10; P = 0.01), and 1-year PPF diagnosis (OR 1.88; 95% CI 1.10 to 3.20; P = 0.02). There were no statistically significant associations between preoperative BP use and the other outcomes in the matched cohort. CONCLUSIONS: These findings suggest that preoperative BP use is associated with an increased risk of revision surgery and PPF in both the short and long term. This information can help in preoperative planning and patient counseling, potentially leading to improved surgical outcomes and reduced complication rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leni and Peter W. May Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
- Leni and Peter W. May Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn…
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- Icahn School of Medicine at Mount Sinai
Zitieren
APA
Busigó Torres, R., Hong, J., Kodali, H., Poeran, J., Stern, B. Z., Hayden, B. L., Chen, D. D., & Moucha, C. S. (2025). Does Preoperative Bisphosphonate Use Impact the Risk of Periprosthetic Fracture Following Total Hip Arthroplasty?. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.08.043
Vancouver
Busigó Torres R, Hong J, Kodali H, Poeran J, Stern BZ, Hayden BL, et al. Does Preoperative Bisphosphonate Use Impact the Risk of Periprosthetic Fracture Following Total Hip Arthroplasty?. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2024.08.043
BibTeX
@article{BusigTorres2025,
author = {Busigó Torres, Rodnell and Hong, James and Kodali, Hanish and Poeran, Jashvant and Stern, Brocha Z and Hayden, Brett L and Chen, Darwin D and Moucha, Calin S},
title = {Does Preoperative Bisphosphonate Use Impact the Risk of Periprosthetic Fracture Following Total Hip Arthroplasty?},
journal = {The Journal of Arthroplasty},
year = {2025},
doi = {10.1016/j.arth.2024.08.043}
}
EUVIMED